Post-earnings recap
Reported
Fri, Feb 23, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Insmed's earnings report showed a significant EPS miss, which typically raises concerns among investors. However, the stock reacted positively, increasing by nearly 6%. This could indicate investor optimism about the company's future potential despite the disappointing earnings performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.85 | N/A | -46.45% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concern over the EPS miss but highlighted ongoing efforts to improve financial performance. They did not provide detailed guidance for the upcoming quarters.
Management did not provide specific revenue figures for the quarter.
The company acknowledged challenges in meeting EPS expectations.